D I V I S I O N OF B R I S T O L - M Y E R S C O M P A N Y 2 2 5 LONG AVENfl'E X HILLSIDE, NEW JERSEY 07207 TELEPHONE 201-923-5000 October 9, 1975 Mr.

r PDEPARTMENT OF HEALTH AND HUMAN SERVIC | December 2, 1983 it I i!

REFERENCES (FDA Docket No. 94P-0420/CP 1) SECTION II.

7.

FILE NAME: Talc (TALC) DATE: 1973 DOC#: TALC075 DOCUMENT DESCRIPTION: Petition to the FDA to Regulate Putting Asbestos in Foods & Drugs BEFORE THE FOOD AND DRUG ADMINISTRATION U.S.

FILE NAME: Talc (TALC) DATE: 1992 DOC#: TALC173 DOCUMENT DESCRIPTION: Journal Article - Biological Effects of Inhaled Minerals SluXUr\< y Q j).

W ILLIAM G.

REMOVAL AND DETECTION OF LIQUID BORNE ASBESTOS FIBERS WITH NUCLEPORE MEMBRANES By Dr.

BEFORE THE FOOD AND DRUG ADMINISTRATION .

Mr.

AmericanJournal ofPathology, Vol. 134, No. 2, February 1989 Copyright American Association o fPathologists Enhanced M acrophage-Fibroblast Interactions in the Pulmonary Interstitium Increases Fibrosis After Silica Injection to MonocyteDepleted Mice I.

Policy Watch Carcinogenicity of carbon black, titanium dioxide, and talc Robert Baan, Kurt Straif Yarn Grasse, Beatrice SeCretan, Fatiha El Ghissassi, Vincent Cogliano, on behalf of the WHO International Agency for Research on Cancer Monograph Working Group In February, 2006, 19 scientists from eight countries met atthe International Agency for Research on Cancer (IARC), Lyon, France, to reassess the carcino genicity of carbon black, titanium dioxide, and non-asbestiform talc.

BETWEEN: SUBJECT: MEMORANDUM OF TELEPHONE CONVERSATION March 19, 1976 Mr.

Lt; * o 1 a:> . o . . ' .